Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
262.05
-2.5 (-0.95%)
BSENSE

Dec 05

BSE+NSE Vol: 2.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
469.48
335.66
349.94
398.52
377.29
292.95
404.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
469.48
335.66
349.94
398.52
377.29
292.95
404.67
Raw Material Cost
129.95
77.00
112.02
132.19
141.95
105.61
103.20
Purchase of Finished goods
59.66
27.02
19.02
14.70
21.17
0.50
1.88
(Increase) / Decrease In Stocks
-31.16
26.11
22.51
6.27
-28.75
-27.09
-12.82
Employee Cost
65.10
58.55
57.91
62.97
58.22
50.03
53.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
0.00
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
2.12
7.68
19.14
23.13
Other Expenses
136.14
119.46
120.54
118.81
95.35
89.56
87.23
Total Expenditure (Excl Depreciation)
359.68
308.15
332.00
337.06
295.62
237.76
255.79
Operating Profit (PBDIT) excl Other Income
109.80
27.51
17.94
61.46
81.67
55.19
148.88
Other Income
11.82
11.81
7.69
8.14
8.25
12.32
12.37
Operating Profit (PBDIT)
121.62
39.32
25.63
69.60
89.92
67.51
161.25
Interest
14.19
17.05
20.78
17.08
17.97
9.09
20.65
Exceptional Items
0.00
-7.43
-28.48
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
107.43
14.84
-23.63
52.52
71.95
58.42
140.60
Depreciation
24.22
24.72
28.25
25.56
20.31
15.00
11.89
Profit Before Tax
83.21
-9.87
-51.87
26.94
51.63
43.42
128.71
Tax
6.81
14.14
1.68
11.88
9.10
-16.10
10.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
76.40
-24.01
-53.55
15.06
42.53
59.52
117.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
76.40
-24.01
-53.55
15.06
42.53
59.52
117.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
-0.43
Minority Interest
0.46
0.95
2.06
0.39
2.98
0.01
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
76.86
-23.06
-51.50
15.45
45.51
59.53
117.45
Equity Capital
14.58
14.44
14.43
14.42
14.42
14.42
4.59
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
348.09
274.42
300.21
357.71
346.17
295.01
227.92
Earnings per share (EPS)
26.36
-7.98
-17.84
5.36
15.78
20.64
42.65
Diluted Earnings per share
26.35
-5.42
-17.85
5.33
15.69
20.53
40.7
Operating Profit Margin (Excl OI)
23.39%
8.2%
5.13%
15.42%
21.65%
18.84%
36.79%
Gross Profit Margin
22.88%
4.42%
-6.75%
13.18%
19.07%
19.94%
34.74%
PAT Margin
16.27%
-7.15%
-15.3%
3.78%
11.27%
20.32%
29.13%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 39.87% vs -4.08% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 433.30% vs 55.22% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 299.13% vs 53.34% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.77% vs -17.95% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Fermenta Biotec. With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
469.48
0
469.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
469.48
0
469.48
Raw Material Cost
129.95
0
129.95
Purchase of Finished goods
59.66
0
59.66
(Increase) / Decrease In Stocks
-31.16
0
-31.16
Employee Cost
65.10
0
65.10
Power Cost
0.00
0
0.00
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
136.14
0.00
136.14
Total Expenditure (Excl Depreciation)
359.68
0
359.68
Operating Profit (PBDIT) excl Other Income
109.80
0.00
109.80
Other Income
11.82
0
11.82
Operating Profit (PBDIT)
121.62
0
121.62
Interest
14.19
0
14.19
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
107.43
0
107.43
Depreciation
24.22
0
24.22
Profit Before Tax
83.21
0
83.21
Tax
6.81
0
6.81
Provisions and contingencies
0.00
0
0.00
Profit After Tax
76.40
0
76.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
76.40
0
76.40
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.46
0
0.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
76.86
0
76.86
Equity Capital
14.58
0
14.58
Face Value
5.00
0
0.00
Reserves
348.09
0
348.09
Earnings per share (EPS)
26.36
0
26.36
Diluted Earnings per share
26.35
0
26.35
Operating Profit Margin (Excl OI)
23.39%
0%
0.00
23.39%
Gross Profit Margin
22.88%
0%
0.00
22.88%
PAT Margin
16.27%
0%
0.00
16.27%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 469.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 39.87% vs -4.08% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 76.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 433.30% vs 55.22% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 109.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 299.13% vs 53.34% in Mar 2024

Annual - Interest
Interest 14.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.77% vs -17.95% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.39%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024